Nanoco Group PLC CEO Q&A: Latest Trading Update (LON:NANO)
17 August 2018
Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a noteworthy player in the biotechnology sector, with a specialization in the discovery, development, and commercialization of innovative therapeutic solutions. Headquartered in Miami,..
Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), has captured the attention of the healthcare sector, particularly with its focus on neurocognitive disorders..
Nuvalent, Inc. (NASDAQ: NUVL) is capturing the attention of investors in the biotechnology sector, thanks to its promising drug pipeline and striking analyst ratings. Headquartered in Cambridge, Massachusetts, this clinical-stage..
Illumina, Inc. (NASDAQ: ILMN), a powerhouse in the diagnostics and research sector of the healthcare industry, stands as a beacon of innovation with its advanced sequencing and array-based solutions. With..
ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is attracting significant attention from investors due to its robust growth metrics and promising future prospects. With a..
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent name in the biotechnology sector, is capturing investor attention with its robust potential upside of 54.23%. Headquartered in West Conshohocken, Pennsylvania, Madrigal is..
Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, is a dynamic player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of..
HealthEquity, Inc. (NASDAQ: HQY), a key player in the healthcare sector, has captured investor attention with its robust growth potential and favorable analyst ratings. Based in Draper, Utah, HealthEquity provides..
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors with its promising growth trajectory in the biotechnology sector. Specializing in novel therapies for central nervous system (CNS) disorders,..
Merit Medical Systems, Inc. (NASDAQ: MMSI) has captured the attention of investors with its impressive growth trajectory and notable potential upside. As a key player in the healthcare sector, specializing..
Moderna, Inc. (MRNA), a titan in the biotechnology sector, has captured global attention with its groundbreaking work in messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts, Moderna has been at..
For investors keen on the healthcare sector, Baxter International Inc. (NYSE: BAX) presents an intriguing opportunity with its current valuation and potential upside. As a stalwart in the medical instruments..
As a stalwart in the healthcare sector, Abbott Laboratories (NYSE: ABT) stands out with its diverse product portfolio and robust market presence. With a market capitalization of $190.38 billion, Abbott..
Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is attracting investor attention with a compelling potential upside of 22.35%. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals is..
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a leader in the biotechnology sector, is fundamentally poised for growth with a market capitalization of $80.33 billion. The company’s robust pipeline and strategic collaborations..
BridgeBio Pharma, Inc. (NASDAQ: BBIO) is emerging as a noteworthy contender in the biotechnology industry, a sector known for its rapid innovations and high-risk, high-reward potential. With a market capitalization..
Roivant Sciences Ltd. (NASDAQ: ROIV), a London-based biopharmaceutical powerhouse, is making waves in the biotechnology sector with its ambitious approach to developing and commercializing groundbreaking medicines and technologies. As it..
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), headquartered in Carlsbad, California, has been a significant player in the biotechnology sector, focusing on the development of RNA-targeted medicines. With a market capitalization of..
Individual investors looking to tap into the burgeoning biotech sector might find Ascendis Pharma A/S (NASDAQ: ASND) an intriguing prospect. With a current market capitalization of $14.77 billion, this Danish..
